Inventor · disambiguated record
Haripada Khatuya
Also filed as: KHATUYA HARIPADA
28 granted patents·20 pending applications·295 citations·filing 1998–2024
97Inventor score
Files withVERTEX PHARMA25ORTHO MCNEIL PHARM INC12BUTLER CHRISTOPHER R2SIRCAR JAGADISH C2BREITENBUCHER J G1
Top patents by PatentIndex Score
48 records- 0198US10793547B2Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2017·Granted Oct 6, 2020·24 cites·21 claims
- 0297US11453655B2Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2020·Granted Sep 27, 2022·8 cites·8 claims
- 0397US10758534B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2019·Granted Sep 1, 2020·13 cites·38 claims
- 0497US10258624B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2017·Granted Apr 16, 2019·32 cites·47 claims
- 0597US9782408B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2015·Granted Oct 10, 2017·33 cites·84 claims
- 0696US11426407B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2020·Granted Aug 30, 2022·6 cites·47 claims
- 0796US10570115B2Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2017·Granted Feb 25, 2020·23 cites·18 claims
- 0895US11066417B2Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorsVERTEX PHARMA·Filed 2019·Granted Jul 20, 2021·13 cites·47 claims
- 0994US11866450B2Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorsVERTEX PHARMA·Filed 2021·Granted Jan 9, 2024·3 cites·41 claims
- 1093US12168009B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2022·Granted Dec 17, 2024·1 cites·46 claims
- 1193US11414439B2Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2019·Granted Aug 16, 2022·6 cites·31 claims
- 1292US11186566B2Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2019·Granted Nov 30, 2021·10 cites·10 claims
- 1391US10738030B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2017·Granted Aug 11, 2020·6 cites·48 claims
- 1490US7772236B2Substituted pyrazolesORTHO MCNEIL PHARM INC·Filed 2008·Granted Aug 10, 2010·9 cites·63 claims
- 1589US6803362B2Heterocyclic compoundsORTHO MCNEIL PHARM INC·Filed 2002·Granted Oct 12, 2004·38 cites·37 claims
- 1688US2025205232A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 1785US7309703B2Substituted pyrazolesORTHO MCNEIL PHARM INC·Filed 2001·Granted Dec 18, 2007·15 cites·41 claims
- 1885US2025171469A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 1982US7393850B2Substituted pyrazolesORTHO MCNEIL PHARM INC·Filed 2006·Granted Jul 1, 2008·3 cites·38 claims
- 2082US6583155B2Method for treating allergies using substituted pyrazolesORTHO MCNEIL PHARM INC·Filed 2002·Granted Jun 24, 2003·15 cites·12 claims
- 2181US12384762B2Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2022·Granted Aug 12, 2025·0 cites·3 claims
- 2278US6953793B2Substituted pyrazolesORTHO MCNEIL PHARM INC·Filed 2001·Granted Oct 11, 2005·11 cites·79 claims
- 2378US2024368189A1Modulators of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the ModulatorsVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 2476US7417046B2Substituted pyrazolesORTHO MCNEIL PHARM INC·Filed 2006·Granted Aug 26, 2008·1 cites·35 claims
- 2576US7332494B2Method for treating allergies using substituted pyrazolesJANSSEN PHARMACEUTICA NV·Filed 2002·Granted Feb 19, 2008·7 cites·2 claims
- 2676US2023312616A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 2771US2022306606A1Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2867US2021139514A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2019·Application pending·0 cites
- 2964US7388011B2Substituted pyrazolesORTHO MCNEIL PHARM INC·Filed 2006·Granted Jun 17, 2008·0 cites·4 claims
- 3064US2025340574A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 3163US7452890B2Substituted pyrazolesORTHO MCNEIL PHARM INC·Filed 2006·Granted Nov 18, 2008·0 cites·34 claims
- 3263US7429591B2Substituted pyrazolesORTHO MCNEIL PHARM INC·Filed 2006·Granted Sep 30, 2008·0 cites·41 claims
- 3363US6384035B1Heterocycles useful in the treatment of benign prostatic hyperplasiaORTHO MCNEIL PHARM INC·Filed 1998·Granted May 7, 2002·18 cites·12 claims
- 3456US2023382925A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3556US2023374038A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3656US2024150377A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3755US2007105841A1Method for treating allergies using substituted pyrazolesBREITENBUCHER J G·Filed 2006·Application pending·0 cites
- 3853US7589202B2Substituted pyrazolesORTHO MCNEIL PHARM INC·Filed 2001·Granted Sep 15, 2009·0 cites·22 claims
- 3953US2007117785A1Substituted pyrazoles and methods of treatment with substituted pyrazolesBUTLER CHRISTOPHER R·Filed 2006·Application pending·0 cites
- 4052US2005085487A1Heterocyclic compoundsFiled 2004·Application pending·0 cites
- 4150US2005245576A1Substituted pyrazolesBUTLER CHRISTOPHER R·Filed 2005·Application pending·0 cites
- 4250US2022313698A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2020·Application pending·0 cites
- 4347US2003073672A1Method for treating allergies using substituted pyrazolesFiled 2001·Application pending·0 cites
- 4447US2005101587A9Method for treating allergies using substituted pyrazolesFiled 2001·Application pending·0 cites
- 4546US2004229927A1Imidazole derivatives for treatment of allergic and hyperproliferative disordersFiled 2004·Application pending·0 cites
- 4642US6841682B2Heterocycles useful in the treatment of benign prostatic hyperplasiaJANSEEN PHARMACEUTICA N V·Filed 2001·Granted Jan 11, 2005·0 cites·2 claims
- 4741US2006009487A1Heterocyclic derivatives for treatment of hyperlipidemia and related diseasesSIRCAR JAGADISH C·Filed 2005·Application pending·0 cites
- 4839US2005277690A1Small molecules for treatment of hypercholesterolemia and related diseasesSIRCAR JAGADISH C·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Haripada Khatuya files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →